Isojacareubin from the Chinese herb Hypericum japonicum: Potent antibacterial and synergistic effects on clinical methicillin-resistant Staphylococcus aureus (MRSA)

International Journal of Molecular Sciences

Volumn 13, Issue 7, 2012, Pages 8210-8218

  Zuo, Guo Ying ^a   An, Jing ^a,b   Han, Jun ^c   Zhang, Yun Ling ^a   Wang, Gen Chun ^a   Hao, Xiao Yan ^b   Bian, Zhong Qi ^a  

^a KUNMING GENERAL HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti MRSA activity; Hypericum japonicum; Isojacareubin; MIC; Synergy

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFTAZIDIME; ISOJACAREUBIN; LEVOFLOXACIN; UNCLASSIFIED DRUG; VANCOMYCIN; XANTHONE DERIVATIVE; ANTIINFECTIVE AGENT; HERBACEOUS AGENT; XANTHENE DERIVATIVE;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BROTH DILUTION; CONTROLLED STUDY; DRUG CONCENTRATION; DRUG POTENTIATION; DRUG STRUCTURE; FRACTIONATION; HYPERICUM; HYPERICUM JAPONICUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMAL BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; BACTERIAL GENE; CHEMISTRY; DISK DIFFUSION; DRUG EFFECTS; GENETICS; IC50; PLANT;

HYPERICUM JAPONICUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; CEFTAZIDIME; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; GENES, BACTERIAL; HYPERICUM; INHIBITORY CONCENTRATION 50; LEVOFLOXACIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PLANT COMPONENTS, AERIAL; XANTHENES;

EID: 84864360543     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13078210     Document Type: Article

References (26)

1. Chang, S.; Sievert, D.M.; Hageman, J.C.; Boulton, M.L.; Tenover, F.C.; Downes, F.P.; Shah, S.; Rudrik, J.T.; Pupp, G.R.; Brown, W.J.; et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 2003, 348, 1342-1347.
2. Wagner, H.; Ulrich-Merzenich, G. Synergy research: Approaching a new generation of phytopharmaceuticals. Phytomedicine 2009, 16, 97-110.
3. Hemaiswarya, S.; Kruthiventi, A.K.; Doble, M. Synergism between natural products and antibiotics against infectious diseases. Phytomedicine 2008, 15, 639-652.
4. Zuo, G.Y.; Wang, G.C.; Zhao, Y.B.; Xu, G.L.; Hao, X.Y.; Han, J.; Zhao, Q. Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). J. Ethnopharmacol. 2008, 120, 287-290.
5. Zuo, G.Y.; Zhang, X.J.; Yang, C.X.; Han, J.; Wang, G.C.; Bian, Z.Q. Evaluation of traditional Chinese medicinal plants for anti-MRSA activity with reference to the treatment record of infectious diseases. Molecules 2012, 17, 2955-2967.
6. Zuo, G.Y.; Meng, F.Y.; Hao, X.Y.; Zhang, Y.L.; Wang, G.C.; Xu, G.L. Antibacterial Alkaloids from Chelidonium majus Linn (Papaveraceae) against clinical isolates of methicillin-resistant Staphylococcus aureus. J. Pharm. Pharm. Sci. 2008, 11, 90-94.
7. Zuo, G.Y.; Li, Y.; Wang, T.; Han, J.; Wang, G.C.; Zhang, Y.L.; Pan, W.D. Synergistic antibacterial and antibiotic effects of bisbenzylisoquinoline alkaloids on clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Molecules 2011, 16, 9819-9826.
8. An, J.; Zuo, G.Y.; Hao, X.Y.; Wang, G.C.; Li, Z.S. Antibacterial and synergy of a flavanonol rhamnoside with antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). Phytomedicine 2011, 18, 990-993.
9. Tian-ji-huang. In Selected Yunnan Traditional Chinese Herbs; Tianjin People's Press: Tianjin, China, 1970; Volume I, pp. 30-31.
10. Di-er-cao. In Dictionary of Chinese Materia Medica; Shanghai Scientific Technical Press: Shanghai, China, 1977; Volume I, pp. 813-814.
11. Ishiguro, K.; Nagata, S.; Fukumoto, H.; Yamaki, M.; Isoi, K.; Oyama, Y. An isopentenylated flavonol from Hypericum japonicum. Phytochemistry 1993, 32, 1583-1585.
12. Zhang, K.; McClure, J.A.; Elsayed, S.; Louie, T.; Conly, J.M. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2005, 43, 5026-5033.
13. Hu, Z.Q.; Zhao, W.H.; Asano, N.; Yoda, Y.; Hara, Y.; Shimamura, T. Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin resistant Staphylococcus aureus. Antimicrob. Agents. Chemother. 2002, 46, 558-560.
14. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing-17th Informational Supplement; Approved Standard M100-S17; CLSI: Wayne, PA, USA, 2007.
15. Petersen, P.J.; Labthavikul, P.; Jones, C.H.; Bradford, P.A. In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J. Antimicrob. Chemother. 2006, 57, 573-576.
16. National Pharmacopoeia Committee of China. Tianjihuang zhusheye (Injectio Hyperici Japonici). In Pharmacopoeia of the People's Republic of China (Part 1); Chemical Industry Press: Beijing, China, 1977; pp. 199-200.
17. Di Carlo, G.; Borrelli, F.; Izzo, A.A.; Ernst, E. St John's wort: Prozac from the plant kingdom. Trends Pharmacol. Set. 2001, 22, 292-297.
18. Chomnawang, M.T.; Surassmo, S.; Wongsariya, K.; Bunyapraphatsara, N. Antibacterial activity of Thai medicinal plants against methicillin-resistant Staphylococcus aureus. Fitoterapia 2009, 80, 102-104.
19. Sukpondma, Y.; Rukachaisirikul, V.; Phongpaichit, S. Antibacterial caged-tetraprenylated xanthones from the fruits of Garcinia hanburyi. Chem. Pharm. Bull. 2005, 53, 850-852.
20. Yasunaka, K.; Abe, F.; Nagayama, A.; Okabe, H.; Lozada-Perez, L.; Lopez-Villafranco, E.; Muniz, E.E.; Aguilar, A.; Reyes-Chilpa, R. Antibacterial activity of crude extracts from Mexican medicinal plants and purified coumarins and xanthones. J. Ethnopharmacol. 2005, 97, 293-299.
21. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved standard M02-A10; CLSI: Wayne, PA, USA, 2006.
22. Kloos, W.K.; Bannerman, T.L. Staphylococcus and Micrococcus. In Manual of Clinical Microbiology, 7th ed.; Murray, P.R., Baron, E.J., Pfaller, M.A., Tenover, F.C., Yolken, R.H., Eds.; ASM Press: Washington, DC, USA, 1999; pp. 264-282.
23. Clinical and Laboratory Standards Institute (CLSI). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 7th ed.; Approved standard M7-A7; CLSI: Wayne, PA, USA, 2006.
24. Clinical Laboratory Standards Institute (CLSI). Methods for Determining Bactericidal Activity of Antimicrobial Agents; Document M26-A; CLSI: Wayne, PA, USA, 1999.
25. Orhan, G.; Bayram, A.; Zer, Y.; Balci, I. Synergy tests by E test and chequerboard methods of antimicrobial combinations against Brucella melitensis. J. Clin. Microbiol. 2005, 43, 140-143.
26. Chin, J.N.; Jones, R.N.; Sader, H.S.; Savage, P.B.; Rybak, M.J. Potential synergy activity of the novel ceragenin, CAS-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J. Antimicrob. Chemother. 2008, 61, 365-370.